Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor Positive, HER2 Negative Breast Cancer Patients

被引：0
|
作者：
Friedman-Eldar, O. [1 ]
Ozmen, T. [1 ]
Reyes, F. Valle [1 ]
Goel, N. [1 ]
Tjendra, Y. [1 ]
Moller, M. [1 ]
Kesmodel, S. B. [1 ]
Franceschi, D. [1 ]
Avisar, E. [1 ]
机构：
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P59
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [41] Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy
    Wang Wenyan
    Wang Xin
    Liu Jiaqi
    Zhu Qiang
    Wang Xiang
    Wang Pilin
    中华医学杂志英文版, 2022, 135 (03) : 333 - 340
  • [42] Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy
    Wang, Xin
    Wang, Wenyan
    Liu, Jiaxiang
    Meng, Xiangzhi
    Liu, Jiaqi
    Guo, Changyuan
    Song, Ying
    Cui, Ningyi
    Li, Qiao
    Xing, Zeyu
    Wang, Jie
    Zhang, Menglu
    Feng, Kexin
    Wang, Pilin
    Wang, Xiang
    CANCER RESEARCH, 2021, 81 (04)
  • [43] Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy
    Wang, Wenyan
    Wang, Xin
    Liu, Jiaqi
    Zhu, Qiang
    Wang, Xiang
    Wang, Pilin
    CHINESE MEDICAL JOURNAL, 2022, 135 (03) : 333 - 340
  • [44] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [45] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [46] The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients
    Lillemoe, T. J.
    Susnik, B.
    Grimm, E.
    Kang, S-H L.
    Swenson, K. K.
    Krueger, J. L.
    Finkelstein, M. J.
    Tsai, M. L.
    CANCER RESEARCH, 2017, 77
  • [47] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [48] Axillary Pathologic Complete Response after Neoadjuvant Systemic Therapy of Breast Cancer in Patients with Initially Clinically Node-Positive Disease
    Cabel, Ma Faustine Juan
    Zaguirre, Karen P.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 236 (05) : S8 - S8
  • [49] ASO Visual Abstract: Axillary Response to Neoadjuvant Therapy in Node-Positive ER+/HER2-Breast Cancer Patients-Predictors and Oncologic Outcomes
    Friedman-Eldar, Orli
    Ozmen, Tolga
    El Haddi, Salah James
    Goel, Neha
    Tjendra, Youley
    Kesmodel, Susan B.
    Moller, Mecker G.
    Franceschi, Dido
    Layton, Christina
    Avisar, Eli
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4102 - 4102
  • [50] Factors Associated With Node-positive Disease in Estrogen Receptor-Positive Breast Cancer Patients
    Gallagher, Julia
    Elleson, Kelly M.
    Englander, Katherine
    Chintapally, Neha
    Sun, Weihong
    Whiting, Junmin
    Laronga, Christine
    Lee, Marie Catherine
    JOURNAL OF SURGICAL RESEARCH, 2024, 295 : 327 - 331
12345